Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
|
|
Washington Post (12.19.01) - Wednesday, December 19, 2001
David Brown
The findings suggest that an unusually large number of people face the possibility that their HIV infections may become difficult to treat. In addition, an increasing fraction of newly infected patients may start out with a resistant microbe. While ominous, the prevalence of drug-resistant virus is a largely unavoidable price of the use of antiretroviral drugs, which have prolonged tens of thousands of lives.
"It's a wake-up call that we've created a lot of resistance with the use of our drugs, and that it's happened in a short period of time," said Douglas D. Richman, a physician at VA San Diego Healthcare System, who presented the study. While not in themselves more virulent, drug-resistant strains are generally more difficult and expensive to treat.
The project sampled about 2,000 HIV-infected people in 33 states, 30 cities and 50 rural areas whose care was provided by 58 major hospitals or organizations and 200 small clinics or individual practitioners. Among those alive in 1999 and under medical care, about 37 percent had no detectable HIV in their blood and presumably harbored no, or virtually no, resistant virus. The remaining 63 percent had detectable virus. These included people taking antiretroviral therapy, people who had taken it and stopped, and people who had never been treated. Of those with detectable virus, 78 percent carried a strain resistant to at least one drug. Overall, 49 percent of participants carried a drug-resistant strain. Numerous experts, however, doubt that drug-resistant strains will become dominant, because they must compete with "wild- type" strains that are more easily transmitted and more biologically fit.
Drug-resistant virus was seen most often in gay white men with good access to health care. This may be because middle-class gay men were the first to use antiretroviral drugs, either singly or in combinations. Use of medicines singly - as was common in the late 1980s and early 1990s -almost always leads to emergence of resistant HIV. Resistance was less common in those treated by physicians with many HIV patients, suggesting that a practitioner's experience and expertise are key to optimal HIV care. Richman said the findings suggest the need for greater use of new lab tests that allow physicians to identify drugs a patient is resistant to before beginning treatment.
011219
AD012196
Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.